Glaucoma
Conditions
Interventions
None listed
Sponsors
Santen Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Phase 1 Newly diagnosed glaucoma patients for April 2016 to May 2016 at clinics introducing of tool. Phase 2 Newly diagnosed glaucoma patients for April 2017 to May 2017 at clinics which persistence rate of out-patients visit is under 70.0% in Phase 1.
Exclusion criteria
Exclusion criteria: Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Persistence rate of out-patients visit after loading tool. | — |
Countries
Japan
Contacts
Public ContactNaomi Otsuka
Santen Pharmaceutical Co., Ltd. Japan Medical Affairs, Development Management Department, Japan Business
Outcome results
None listed